MSD for Mothers (also known as Merck for Mothers), is a 10‐year global initiative to address one of the world’s oldest and most preventable health tragedies – the death of a woman from complications experienced during pregnancy and childbirth. The focus is on the two leading causes of death - post-partum hemorrhage and preeclampsia - as well as family planning, which is known to play an important role in saving women’s lives.
Working closely with governments, international organizations, health experts, and those on the front lines, Merck’s goal is to help women across the world be well. Merck for Mothers was officially launched in 2005 at the United Nations and joined the global effort to achieve United Nations Millennium Development Goal 5 (MDG 5), which calls for a 75 percent reduction in maternal mortality by 2015 and universal access to reproductive health care. MSD for Mothers builds on Merck’s legacy of taking on urgent global health challenges. The company is applying its scientific expertise, business skills, and financial and human resources to the effort.
MSD for Mothers has a three‐pronged strategy: 1) accelerate access to affordable high quality care; 2) advocate and increase awareness about maternal mortality and morbidity; and 3) advance product innovations to save women’s lives. MSD for Mothers is working with approximately 75 partners on more than 50 projects to improve the maternal health of women in 30 countries.
|Location||Latin America and Caribbean, North America, Brazil, India, Senegal, Uganda, United States, Wallis and Futuna, Zambia|